|
MMRI provides the critical infrastructure and IP neutral research location
for new pharmaceutical, medical device and biotechnology companies. Whether a
new start-up, spin-out or commercialization, MMRI is the high efficiency choice
for rapid starting your research. Our unique SRA based approach has yielded a
92% success rate for MMRI affiliate companies over our fourteen year
history.
CURRENT AFFILIATES
Altravax
Aravasc, Inc.
Bayhill Therapeutics
Bioexpertise, Inc.
Epiphany Biosciences
Mayflower Organization for Research and
Education
Ontherix, Inc.
Pharmadyn, Inc.
PharmaGenius, Inc.
Plaxgen, Inc.
Protigen, Inc.
STATegics, Inc.
Theracos, Inc.
Trigemina, Inc.
FORMER AFFILIATES
Abmaxis, Inc.
Aggregate Therapeutics, Inc.
Alvine Pharmaceuticals, Inc.
Applied Genomics, Inc.
Arbor Vita, Corporation
Ardelyx, Inc. (Formerly Nteryx)
BAS Medical/Corthera
Beausyn
Labs
Celiac Sprue Research Foundation
ChemoCentryx
Cognate
Therapeutics
Cytokine Networks
FreshGene, Inc.
Gene Security Network
GMR
Epigenetics, Inc.
Imedd, Inc.
Inverseon, Inc.
Juvaris
BioTherapeutics
Molecon
Myoscience
Neosil, Inc.
New Millennium,
Inc.
Nuvelo (formerly Hyseq)
PLC Diagnostics, Inc.
Primity, Inc.
Raven biotechnologies, inc.
Regulon, Inc.
Reconstructive Technologies,
Inc.
SanBio, Inc.
SomaGenics, Inc.
Sunny BioDiscovery, Inc.
SynthoChirals
Theron
Pharmaceuticals, Inc.
Threshold
Pharmaceuticals
VistaGen Therapeutics,
Inc.
EXTERNAL COLLABORATIONS
MMRI has a broad range of scientific expertise and an extensive
collaborative network and therefore can provide scientific support and
collaborations with biotechnology and pharmaceutical companies who are
interested in initiating a project while limiting the risk of investing in
personnel or new equipment at the proof of concept stage.
|
